Abstract
Combinations of doxorubicin and streptozocin and 5-FU and dacarbazine were given alternately to 20 patients with metastatic medullary thyroid carcinoma. Three partial responses and 10 long-term stabilizations were observed. No unexpected toxicity occurred. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Brierley J, Tsang R, Simpson WJ, Gospodarowicz M, Sutcliffe S and Panzarella T (1996) Medullary thyroid cancer: analysis of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 6: 305–310
Cailleux AF and Schlumberger MJ (1998) Chemotherapy and biological therapy of thyroid cancer. In: Thyroid cancer, J Fagin (ed), Kluwer Academic Publishers: Boston. pp. 341–350
Chi DD and Moley JF (1998) Medullary thyroid carcinoma: genetic advances, treatment recommendation and the approach to the patient with persistent hypercalcitoninemia. Surg Oncol Clin N Am 7: 681–706
De Besi P, Busnardo B, Toso S, Girelli ME, Nacamulli D, Simioni N, Casara D, Zorat P and Fiorentino MV (1991) Combined chemotherapy with bleomycin, adriamycin and platinum in advanced thyroid cancer. J Endocrinol Invest 14: 475–480
Di Bartolomeo M, Bajetta E, Bochicchio AM, Carnaghi C, Somma L, Mazzaferro V, Visini M, Gebbia V, Tumolo S and Ballatore P (1995) A phase II trial of dacarbazine, fluorouracil and epirubicin in patient with neuroendocrine tumors. A study by the italian trials in medical oncology (ITMO) group. Ann Oncol 6: 77–79
Droz JP, Schlumberger M, Rougier P, Ghosn M, Gardet P and Parmentier C (1990) Chemotherapy in metastatic non anaplastic thyroid cancer: experience at the Institut Gustave-Roussy. Tumori 76: 480–483
Fife KM, Bower M and Harmer CL (1996) Medullary thyroid cancer: the role of radiotherapy in local control. Eur J Surg Oncol 22: 588–591
Frame J, Kelsen D, Kemeny N, Cheng E, Niedzwiecki D, Heelan R and Lipperman RA (1988) A phase II trial of streptozotocin and adriamycin in advanced APUD tumors. Am J Clin Oncol 11: 490–495
Hoskin PJ and Harmer C (1987) Chemotherapy for thyroid cancer. Radiother Oncol 10: 187–194
Miller AB, Hoogstraten B, Staquet M and Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207–214
Moertel CG, Johnson CM, McKusick JK Jr, Nagorney DM, Kvols LK, Rubin J and Kunselman S (1994) The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 120: 302–309
Orlanci F, Caraci P, Berruti A, Puligheddu B, Pivano G, Dogliotti L and Angeli A (1994) Chemotherapy with dacarbazine and 5-fluoro-uracil in advanced medullary thyroid cancer. Ann Oncol 5: 763–765
Petursson SR (1988) Metastatic medullary thyroid carcinoma: complete response to combination chemotherapy with dacarbazine and 5-fluoro-uracil. Cancer 62: 1899–1903
Saad MF, Ordonez NG, Rashid RK, Guido JJ, Hill CS, Hickey RC and Saaman NA (1984) Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine (Baltimore) 63: 319–342
Schlumberger M and Pacini F (1999) Medullary thyroid carcinoma. In: Thyroid tumors. Editions Nucléon, Paris. pp 267–299
Schlumberger M, Abdelmoumene N, Delisle MJ and Couette JE (1995) Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. Br J Cancer 71: 363–365 365
Shimaoka K, Schoenfeld DA, De Wys WD, Creech RH and De Conti R (1985) A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 56: 2155–2160
Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P and Sarrazin D (1985) External radiotherapy in thyroid cancers. Cancer 55: 2062–2071
Van Heerden JA, Grant CS, Gharib H, Hay ID and Illstrup DM (1990) Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212: 395–401
Williams SD, Birch R and Einhorn LH (1986) Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a southeastern cancer study group trial. Cancer Treat Rep 70: 405–407
Wu LT, Averbuch SD, Ball DW, De Bustros A, Baylin SB and Mac Guire, III WP (1994) Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine and dacarbazine. Cancer 73: 432–436
Yang KP, Liamg YF and Samaan NA (1991) Intrinsic drug resistance in a human medullary thyroid carcinoma cell line: association with overexpression of mdrl gene and low proliferation fraction. Anticancer Res 11: 1065–1068
Author information
Authors and Affiliations
Consortia
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Nocera, M., Baudin, E., Pellegriti, G. et al. Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Br J Cancer 83, 715–718 (2000). https://doi.org/10.1054/bjoc.2000.1314
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1314
Keywords
This article is cited by
-
Das medulläre Schilddrüsenkarzinom: Fokus systemische Therapie
Journal für Klinische Endokrinologie und Stoffwechsel (2020)
-
Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression
Endocrine Pathology (2016)